CN102210812A - 一种复方瑞他莫林药物膜剂及其制备方法 - Google Patents
一种复方瑞他莫林药物膜剂及其制备方法 Download PDFInfo
- Publication number
- CN102210812A CN102210812A CN2011101527916A CN201110152791A CN102210812A CN 102210812 A CN102210812 A CN 102210812A CN 2011101527916 A CN2011101527916 A CN 2011101527916A CN 201110152791 A CN201110152791 A CN 201110152791A CN 102210812 A CN102210812 A CN 102210812A
- Authority
- CN
- China
- Prior art keywords
- tamolin
- rui
- membrane
- retapamulin
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 36
- 150000001875 compounds Chemical class 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 6
- STZYTFJPGGDRJD-NHUWBDDWSA-N retapamulin Chemical compound C([C@H]([C@@]1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]2C)OC(=O)CS[C@@H]3C[C@H]4CC[C@H](N4C)C3)C)C[C@]32[C@H]1C(=O)CC3 STZYTFJPGGDRJD-NHUWBDDWSA-N 0.000 title abstract description 10
- 229960002771 retapamulin Drugs 0.000 title abstract description 9
- 230000000694 effects Effects 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 3
- 239000003814 drug Substances 0.000 claims description 69
- 229940079593 drug Drugs 0.000 claims description 10
- 108010010803 Gelatin Proteins 0.000 claims description 7
- 229920000159 gelatin Polymers 0.000 claims description 7
- 239000008273 gelatin Substances 0.000 claims description 7
- 235000019322 gelatine Nutrition 0.000 claims description 7
- 235000011852 gelatine desserts Nutrition 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 229960002233 benzalkonium bromide Drugs 0.000 claims description 2
- KHSLHYAUZSPBIU-UHFFFAOYSA-M benzododecinium bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 KHSLHYAUZSPBIU-UHFFFAOYSA-M 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 206010052428 Wound Diseases 0.000 abstract description 23
- 208000027418 Wounds and injury Diseases 0.000 abstract description 23
- 208000015181 infectious disease Diseases 0.000 abstract description 11
- 230000035876 healing Effects 0.000 abstract description 3
- 210000003677 hemocyte Anatomy 0.000 abstract description 2
- 229940000351 hemocyte Drugs 0.000 abstract description 2
- 230000002458 infectious effect Effects 0.000 abstract description 2
- 210000003734 kidney Anatomy 0.000 abstract description 2
- 210000004185 liver Anatomy 0.000 abstract description 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 241001313855 Bletilla Species 0.000 abstract 1
- 241000099774 Cuscuta salina Species 0.000 abstract 1
- 244000153955 Reynoutria sachalinensis Species 0.000 abstract 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 231100000956 nontoxicity Toxicity 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
- 210000001835 viscera Anatomy 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 description 6
- 206010053692 Wound complication Diseases 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 4
- MINDHVHHQZYEEK-UHFFFAOYSA-N (E)-(2S,3R,4R,5S)-5-[(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy-(beta)-methyl-2H-pyran-2-crotonic acid ester with 9-hydroxynonanoic acid Natural products CC(O)C(C)C1OC1CC1C(O)C(O)C(CC(C)=CC(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-UHFFFAOYSA-N 0.000 description 3
- 206010021531 Impetigo Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 241000193996 Streptococcus pyogenes Species 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- DDHVILIIHBIMQU-YJGQQKNPSA-L mupirocin calcium hydrate Chemical compound O.O.[Ca+2].C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1.C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1 DDHVILIIHBIMQU-YJGQQKNPSA-L 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 230000000472 traumatic effect Effects 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 229960001716 benzalkonium Drugs 0.000 description 2
- -1 benzalkonium bromides Chemical class 0.000 description 2
- 238000001804 debridement Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 229960003128 mupirocin Drugs 0.000 description 2
- 229930187697 mupirocin Natural products 0.000 description 2
- ZRZNJUXESFHSIO-VYTKZBNOSA-N pleuromutilin Chemical compound C([C@H]([C@]1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]2C)OC(=O)CO)C)C[C@]32[C@H]1C(=O)CC3 ZRZNJUXESFHSIO-VYTKZBNOSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- UURAUHCOJAIIRQ-QGLSALSOSA-N tiamulin Chemical compound CCN(CC)CCSCC(=O)O[C@@H]1C[C@@](C)(C=C)[C@@H](O)[C@H](C)[C@@]23CC[C@@H](C)[C@]1(C)[C@@H]2C(=O)CC3 UURAUHCOJAIIRQ-QGLSALSOSA-N 0.000 description 2
- 229960004885 tiamulin Drugs 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- LLYYNOVSVPBRGV-MVNKZKPCSA-N valnemulin Chemical compound CC(C)[C@@H](N)C(=O)NCC(C)(C)SCC(=O)O[C@@H]1C[C@@](C)(C=C)[C@@H](O)[C@H](C)[C@@]23CC[C@@H](C)[C@]1(C)[C@@H]2C(=O)CC3 LLYYNOVSVPBRGV-MVNKZKPCSA-N 0.000 description 2
- 229950008166 valnemulin Drugs 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 241001572230 Clitopilus passeckerianus Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010014568 Empyema Diseases 0.000 description 1
- 241000588697 Enterobacter cloacae Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- ZRZNJUXESFHSIO-UHFFFAOYSA-N Pleuromutilin Natural products CC1C(O)C(C)(C=C)CC(OC(=O)CO)C2(C)C(C)CCC31C2C(=O)CC3 ZRZNJUXESFHSIO-UHFFFAOYSA-N 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000034777 Vitreous degeneration Diseases 0.000 description 1
- 206010048629 Wound secretion Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 229940061806 altabax Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940028420 bactroban Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000012622 synthetic inhibitor Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 201000011288 vitreous syneresis Diseases 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110152791 CN102210812B (zh) | 2011-06-09 | 2011-06-09 | 一种复方瑞他莫林药物膜剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110152791 CN102210812B (zh) | 2011-06-09 | 2011-06-09 | 一种复方瑞他莫林药物膜剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102210812A true CN102210812A (zh) | 2011-10-12 |
CN102210812B CN102210812B (zh) | 2013-06-12 |
Family
ID=44742496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110152791 Active CN102210812B (zh) | 2011-06-09 | 2011-06-09 | 一种复方瑞他莫林药物膜剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102210812B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103709102A (zh) * | 2012-09-28 | 2014-04-09 | 山东亨利医药科技有限责任公司 | 含有螺环的截短侧耳素类抗生素 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1202365A (zh) * | 1997-06-13 | 1998-12-23 | 湖南中医学院第一附属医院 | 春雨烧烫伤膏 |
-
2011
- 2011-06-09 CN CN 201110152791 patent/CN102210812B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1202365A (zh) * | 1997-06-13 | 1998-12-23 | 湖南中医学院第一附属医院 | 春雨烧烫伤膏 |
Non-Patent Citations (6)
Title |
---|
《天津药学》 20081228 叶立 治疗疱疹病毒的新药__瑞他莫林(retapamulin) 75-76 1-2 第20卷, 第06期 * |
《湖南中医药导报》 20020330 左亚杰等 烧伤药物的研究进展 106-108 1-2 第8卷, 第03期 * |
叶立: "治疗疱疹病毒的新药――瑞他莫林(retapamulin) ", 《天津药学》 * |
叶立: "治疗疱疹病毒的新药――瑞他莫林(retapamulin)", 《天津药学》, vol. 20, no. 06, 28 December 2008 (2008-12-28), pages 75 - 76 * |
左亚杰等: "烧伤药物的研究进展 ", 《湖南中医药导报》 * |
左亚杰等: "烧伤药物的研究进展", 《湖南中医药导报》, vol. 8, no. 03, 30 March 2002 (2002-03-30), pages 106 - 108 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103709102A (zh) * | 2012-09-28 | 2014-04-09 | 山东亨利医药科技有限责任公司 | 含有螺环的截短侧耳素类抗生素 |
CN103709102B (zh) * | 2012-09-28 | 2015-08-12 | 山东亨利医药科技有限责任公司 | 含有螺环的截短侧耳素类抗生素 |
Also Published As
Publication number | Publication date |
---|---|
CN102210812B (zh) | 2013-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070098671A1 (en) | Composition and method of treatment for irritated skin | |
JP6239041B2 (ja) | 微生物感染の治療に使用するためのタマリンド種子多糖 | |
US20190008905A1 (en) | Compositions for management of wounds, skin diseases, dehydration, chronic diseases, and respiratory diseases | |
CN103451032A (zh) | 安全环保茶籽洗洁粉及其制备方法 | |
JPH04501106A (ja) | 動物およびヒトにおける乳腺炎の治療用医薬 | |
CN106511267A (zh) | 复方莫昔克丁滴剂及其制备方法和应用 | |
CN107496977B (zh) | 一种用纯天然植物提取物制备的液体敷料及其制备方法 | |
RU2419449C1 (ru) | Средство для лечения больных лекарственным гепатитом | |
Mahajan et al. | Miraculous benefits of cow urine: a review | |
WO2008104076A1 (en) | Electrocolloidal silver and echinacea root antimicrobial formulation | |
CN100431617C (zh) | 含有柑橘精华的杀菌消毒液 | |
CN102210812B (zh) | 一种复方瑞他莫林药物膜剂及其制备方法 | |
Sharma et al. | Cow urine prominence to humanity | |
CN106237029B (zh) | 一种芦荟抗菌凝胶及其制备方法 | |
DG et al. | Management of surgical wounds using crude neem oil in one year old ram: A successful report | |
RU2577950C1 (ru) | Способ стимуляции заживления дермальных ожогов | |
CN106236835A (zh) | 一种植物精油喷剂及其制备方法和应用 | |
CN106963974A (zh) | 一种含紫草素的创可贴及其制备方法 | |
RU2443427C1 (ru) | Антигельминтное средство | |
CN104257913A (zh) | 治疗奶牛***炎的中药浓缩液及由该浓缩液制备的涂膜剂 | |
RU2165253C2 (ru) | Способ лечения онкозаболеваний | |
CN109453146A (zh) | 抗病原微生物的组合物及其制备方法和应用 | |
RU2280458C1 (ru) | Противовоспалительная мазь | |
Singh | Biochemical appraisal of Gomutra (Cow urine) | |
CN108420829B (zh) | 一种宠物用消肿生肌膏 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Compound Ritamorin Drug Membrane and Its Preparation Method Effective date of registration: 20231226 Granted publication date: 20130612 Pledgee: Agricultural Bank of China Limited Linfen Pingyang Branch Pledgor: SHANXI XINYUAN HUAKANG CHEMICAL Co.,Ltd. Registration number: Y2023140000070 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
CP03 | Change of name, title or address |
Address after: 041000 Hexi Industrial Zone, Yaodu District, Linfen City, Shanxi Province (former Fenhe pharmaceutical factory) Patentee after: Shanxi Xinyuan Huakang Biotechnology Co.,Ltd. Country or region after: China Address before: 041000 Shanxi Xinyuan Huakang Chemical Company, Hexi Industrial Zone, Linfen City, Shanxi Province Patentee before: SHANXI XINYUAN HUAKANG CHEMICAL Co.,Ltd. Country or region before: China |